Albertsons Companies (ACI)
NYSE:ACI
Want to see ACI full AI Analyst Report?
Top Page
Albertsons Companies
(NYSE:ACI)
Select Model
Select Model
Rating:51Neutral
Price Target:
$16.50
▼(-1.20% Downside)
Action:ReiteratedDate:04/17/26
The score is held back primarily by weakened recent profitability, reduced free cash flow, and high leverage, alongside bearish price momentum. These negatives are partially offset by a low P/E with dividend support and a generally constructive FY26 outlook emphasizing productivity initiatives and shareholder returns despite near-term pharmacy and demand headwinds.
Positive Factors
Digital & Loyalty Scale
Sustained digital penetration (>10%) and 16% growth plus 51M loyalty members create a durable first-party data and fulfillment advantage. This raises customer frequency, enables higher-margin retail media, and supports personalized promotions, improving long-term revenue mix and competitive positioning.
Negative Factors
High Leverage
A large debt load (~$15.3B) versus a small equity base (~$1.8B) leaves the capital structure highly leveraged and sensitive to earnings volatility. This constrains strategic flexibility, amplifies interest costs, and raises refinancing and covenant risks if profitability or cash flow weaken materially over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Digital & Loyalty Scale
Sustained digital penetration (>10%) and 16% growth plus 51M loyalty members create a durable first-party data and fulfillment advantage. This raises customer frequency, enables higher-margin retail media, and supports personalized promotions, improving long-term revenue mix and competitive positioning.
Read all positive factors
Albertsons Companies (ACI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$8.52B
Dividend Yield3.49%
Average Volume (3M)7.09M
Price to Earnings (P/E)44.9
Beta (1Y)0.05
Revenue Growth3.46%
EPS Growth-80.55%
CountryUS
Employees108,300
SectorConsumer Defensive
Sector Strength42
IndustryGrocery Stores
Share Statistics
EPS (TTM)0.48
Shares Outstanding513,913,150
10 Day Avg. Volume9,462,748
30 Day Avg. Volume7,094,197
Financial Highlights & Ratios
PEG Ratio-0.59
Price to Book (P/B)5.31
Price to Sales (P/S)0.12
P/FCF Ratio18.51
Enterprise Value/Market Cap2.77
Enterprise Value/Revenue0.28
Enterprise Value/Gross Profit1.06
Enterprise Value/Ebitda6.89
Forecast
1Y Price Target
$21.27Price Target Upside27.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)2.27
Revenue Forecast (FY)$82.49B
Albertsons Companies Business Overview & Revenue Model
Company Description
Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States. The company's food and drug retail stores offer grocery products, general merchandise, health and beauty care products, ph...
How the Company Makes Money
Albertsons primarily makes money by selling consumer packaged goods and fresh food through its retail stores and digital channels, generating revenue at checkout from grocery, produce, meat/seafood, deli/bakery, dairy, frozen, beverages, and gener...
Albertsons Companies Earnings Call Summary
Earnings Call Date:Apr 14, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Jul 28, 2026
Earnings Call Sentiment Positive
The call balanced clear evidence of operational progress — strong adjusted EBITDA and EPS performance, digital and loyalty momentum, an upgraded $2.0B productivity program, continued shareholder returns, and a manageable leverage profile — against material near-term retail and pharmacy headwinds (IRA-driven pharmacy pressure, GLP-1 moderation, unit pressure in lower-income cohorts, egg deflation and a recorded $774M opioid settlement framework). Management presented a constructive FY26 outlook with modest EBITDA and EPS growth, continued investment in AI/technology and an expanded share-repurchase authorization while acknowledging a challenging Q1 cadence. Overall, positives around productivity, digital/loyalty scale and capital allocation appear to outweigh the near-term challenges, with leadership confidence that investments and AI-driven initiatives will drive sequential improvement through the year.Positive Updates
Q4 Adjusted EBITDA and EPS Beat
Adjusted EBITDA of $903 million in Q4 (includes ~ $68 million from 53rd week) and adjusted diluted EPS of $0.48, delivered better-than-expected results despite pharmacy headwinds.
Negative Updates
Pharmacy Headwinds and IRA Impact
Pharmacy created an approximate 145 basis point headwind to Q4 identical sales (IRA pricing/mix ~105 bps and GLP-1 moderation ~40 bps). Management expects the IRA to create ~150 bps of reported headwind in FY26 guidance.
Read all updates
Q4-2025 Updates
Positive
Negative
Q4 Adjusted EBITDA and EPS Beat
Adjusted EBITDA of $903 million in Q4 (includes ~ $68 million from 53rd week) and adjusted diluted EPS of $0.48, delivered better-than-expected results despite pharmacy headwinds.
Read all positive updates
Company Guidance
Albertsons guided fiscal 2026 to identical sales of 0%–1% (or 1.5%–2.5% excluding an estimated ~150 bps IRA headwind), with Q1 expected below the full‑year range and sequential improvement thereafter; adjusted EBITDA of $3.85–$3.925 billion (≈2.5% growth at the high end, ex‑53rd week), adjusted EPS of $2.22–$2.32 (assuming ~ $600 million of share repurchases in FY26), an effective tax rate of 24%–25%, and CapEx of $2.0–$2.2 billion. Management refreshed a $2 billion share‑repurchase authorization to be executed opportunistically over ~3 years, increased the quarterly dividend 13% to $0.68 per share, and reiterated a $2 billion, three‑year productivity target; FY25 metrics cited as context included $3.9 billion adjusted EBITDA, Q4 adjusted EBITDA $903 million (incl. ≈$68M from the 53rd week), FY25 identical sales +2% (Q4 +0.7% net of ~145 bps pharmacy headwinds), net debt/adjusted EBITDA of 2.24x, a recorded $774 million proposed opioid settlement payable over 9 years, digital penetration >10% with Q4 digital growth +16% (≈90% first‑party), membership >51 million (+12%), and retail media personalized ad pilots showing ~90% lift in conversion/CTR.Albertsons Companies Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
38
Negative
Cash Flow
55
Neutral
| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 83.17B | 80.39B | 79.24B | 77.65B | 71.89B |
| Gross Profit | 20.90B | 22.26B | 22.05B | 21.76B | 20.72B |
| EBITDA | 3.36B | 4.08B | 4.53B | 4.85B | 4.87B |
| Net Income | 217.40M | 958.60M | 1.30B | 1.51B | 1.62B |
Balance Sheet | |||||
| Total Assets | 26.77B | 29.31B | 28.79B | 28.75B | 30.77B |
| Cash, Cash Equivalents and Short-Term Investments | 198.60M | 339.20M | 212.00M | 477.20M | 2.97B |
| Total Debt | 15.30B | 14.18B | 14.24B | 15.01B | 15.30B |
| Total Liabilities | 24.93B | 25.92B | 26.05B | 27.14B | 27.75B |
| Stockholders Equity | 1.84B | 3.39B | 2.75B | 1.61B | 3.02B |
Cash Flow | |||||
| Free Cash Flow | 527.30M | 749.40M | 628.20M | 700.00M | 1.91B |
| Operating Cash Flow | 2.37B | 2.68B | 2.66B | 2.85B | 3.51B |
| Investing Cash Flow | -1.68B | -1.89B | -1.75B | -1.98B | -1.54B |
| Financing Cash Flow | -782.20M | -684.10M | -1.18B | -3.37B | -789.50M |
Albertsons Companies Technical Analysis
Negative
16.70
Price Trends
17.45
Negative
17.31
Negative
18.01
Negative
Market Momentum
-0.18
Positive
44.33
Neutral
27.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ACI, the sentiment is Negative. The current price of 16.7 is below the 20-day moving average (MA) of 17.11, below the 50-day MA of 17.45, and below the 200-day MA of 18.01, indicating a bearish trend. The MACD of -0.18 indicates Positive momentum. The RSI at 44.33 is Neutral, neither overbought nor oversold. The STOCH value of 27.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ACI.
Albertsons Companies Risk Analysis
Albertsons Companies disclosed 38 risk factors in its most recent earnings report. Albertsons Companies reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Albertsons Companies Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $6.77B | 15.05 | 38.21% | ― | 14.08% | 41.23% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | $1.67B | 11.86 | 5.93% | 0.93% | -0.51% | 20.82% | |
58 Neutral | $1.68B | 17.84 | 6.83% | 2.06% | 3.48% | -11.62% | |
55 Neutral | $40.37B | 40.33 | 13.04% | 2.15% | 0.35% | -57.81% | |
51 Neutral | $8.52B | 44.89 | 8.17% | 3.49% | 3.46% | -80.55% | |
46 Neutral | $786.21M | -4.43 | -19.78% | ― | 7.26% | -673.24% |
* Consumer Defensive Sector Average
ACI
Albertsons Companies
16.48
-4.76
-22.42%
IMKTA
Ingles Markets
89.04
27.90
45.63%
KR
Kroger Company
67.10
-3.66
-5.18%
WMK
Weis Markets
69.31
-15.10
-17.89%
SFM
Sprouts Farmers
71.13
-99.87
-58.40%
GO
Grocery Outlet Holding
7.69
-9.10
-54.20%
Albertsons Companies Corporate Events
Business Operations and StrategyStock BuybackDividendsFinancial DisclosuresLegal ProceedingsPrivate Placements and Financing
Albertsons Announces Opioid Settlement Framework and Outlook
Negative
Apr 14, 2026
On April 14, 2026, Albertsons unveiled a settlement framework to resolve substantially all opioid-related claims from participating states, local governments and Native American tribes, agreeing to pay about $774 million over nine years, with the ...
Business Operations and StrategyExecutive/Board Changes
Albertsons Adds Tech-Focused Independent Director to Board
Positive
Feb 27, 2026
On February 25, 2026, Albertsons Companies, Inc. appointed Brian Rice, Executive Vice President and Global Chief Information Officer at McDonald’s Corporation, to its Board of Directors, expanding the board from 10 to 11 members for a term r...
Business Operations and StrategyPrivate Placements and Financing
Albertsons Companies Issues New Senior Notes to Refinance Debt
Positive
Feb 2, 2026
On February 2, 2026, Albertsons Companies and certain subsidiaries issued $1.2 billion of new 5.625% senior notes due 2032 and $900 million of additional 5.750% senior notes due 2034 in a private offering to institutional and non-U.S. investors un...
Business Operations and StrategyPrivate Placements and Financing
Albertsons launches refinancing to extend debt maturities
Positive
Jan 22, 2026
On January 22, 2026, Albertsons Companies and several subsidiaries launched a refinancing push in the bond market, announcing plans to redeem in cash the full $1.35 billion of 4.625% senior notes due 2027 and the $750 million of 5.875% senior note...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.